Chad Winch

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

James Perry, Normand Laperrière, Christopher J. O’Callaghan et al. · New England Journal of Medicine · 2017 · 1.2K citations · Full text

Medicine, Oncology, Radiation Oncology +17

OV21/PETROC: a randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer

Diane Provencher, C. Gallagher, Wendy R. Parulekar et al. · Annals of Oncology · 2017 · 66 citations · Full text

Medicine, Oncology, Surgery +15

A phase III randomized controlled trial of short-course radiotherapy with or without concomitant and adjuvant temozolomide in elderly patients with glioblastoma (CCTG CE.6, EORTC 26062-22061, TROG 08.02, NCT00482677).

James Perry, Normand Laperrière, Christopher J. O’Callaghan et al. · Journal of Clinical Oncology · 2016 · 53 citations

Medicine, Oncology, Radiation Oncology +17

A phase III randomized controlled trial of short-course radiotherapy with or without concomitant and adjuvant temozolomide in elderly patients with glioblastoma multiforme

James Perry, Chris J. O’Callaghan, Keyue Ding et al. · Neuro-Oncology · 2010 · 26 citations

Medicine, Geriatric Medicine, Oncology +17

A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†

Tony Reiman, Kerry J. Savage, Michael Crump et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2018 · 25 citations

Medicine, Oncology, Pharmacology +12